Literature DB >> 9284079

Effect of estradiol metabolites on the susceptibility of low density lipoprotein to oxidation.

H Seeger1, A O Mueck, T H Lippert.   

Abstract

The main estradiol metabolites 2-hydroxyestrone, 2-methoxyestrone and 16alpha-hydroxyestrone were investigated in vitro for the susceptibility of low density lipoprotein to oxidation and the effects compared with those of estradiol and vitamin E. 2-hydroxyestrone and 2-methoxyestrone had a greater inhibitory effect than estradiol and vitamin E whereas 16alpha-hydroxyestrone approximates the inhibition of estradiol. These results indicate that 2-hydroxyestrone and 2-methoxyestrone possess non-genomic actions which may play a role in the lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284079     DOI: 10.1016/s0024-3205(97)00588-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

2.  Dietary fiber and serum 16α-hydroxyestrone, an estrogen metabolite associated with lower systolic blood pressure.

Authors:  Shawn Patel; Louise C Hawkley; John T Cacioppo; Christopher M Masi
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

3.  2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice.

Authors:  Ajeeth K Pingili; Karen N Davidge; Shyamala Thirunavukkarasu; Nayaab S Khan; Akemi Katsurada; Dewan S A Majid; Frank J Gonzalez; L Gabriel Navar; Kafait U Malik
Journal:  Hypertension       Date:  2017-04-17       Impact factor: 10.190

4.  Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.

Authors:  MaryFran Sowers; Daniel McConnell; Mary L Jannausch; John F Randolph; Robert Brook; Ellen B Gold; Sybil Crawford; Bill Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

5.  Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".

Authors:  MaryFran R Sowers; John Randolph; Mary Jannausch; Bill Lasley; Elizabeth Jackson; Daniel McConnell
Journal:  Arch Intern Med       Date:  2008-10-27

6.  Serum estrogen metabolites and systolic blood pressure among middle-aged and older women and men.

Authors:  Christopher M Masi; Louise C Hawkley; Xia Xu; Timothy D Veenstra; John T Cacioppo
Journal:  Am J Hypertens       Date:  2009-08-27       Impact factor: 2.689

7.  2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy.

Authors:  Zaid H Maayah; Jody Levasseur; Ramanaguru Siva Piragasam; Ghada Abdelhamid; Jason R B Dyck; Richard P Fahlman; Arno G Siraki; Ayman O S El-Kadi
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

8.  Urinary estrogen levels in women on contraceptives in enugu, South-East Nigeria.

Authors:  Ignatius C Maduka; Francis E Ezeonu; Emeka E Neboh; Elvis N Shu; Ebele J Ikekpeazu
Journal:  J Family Med Prim Care       Date:  2012-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.